THETERMARTIFICIALBLOODISSOMEWHATMISLEADINGTHEREISNOONEPRODUCTTHATISBEINGDESIGNEDTOREPLACETHEFUNCTIONOFHUMANBLOODTHEREARETWOMAINCATEGORIESWHICHCONSISTOFVOLUMEEXPANDERSWHICHONLYINCREASEBLOODVOLUMEANDOXYGENTHERAPEUTICSWHICHSUBSTITUTEFORTHEBLOODSNATURALABILITYTOCARRYOXYGENWENEEDBLOODSUBSTITUTESDUETOINCREASINGDEMANDSACCORDINGTOTHEAMERICANREDCROSSBLOODDONATIONISINCREASINGANNUALLYINTHEUNITEDSTATESBUTTHEDEMANDSTEADILYISCLIMBINGBYBETWEENTHEDEMANDISCLIMBINGDUETOTHEFACTTHATOURPOPULATIONISAGINGANDMOREOPERATIONSAREINVOLVINGTHEUSEOFBLOODANDBLOODTRANSFUSIONSANOTHERREASONFORINCREASINGDEMANDSISDUETODEVELOPINGNATIONSAPPROPRIATELYMILLIONUNITSOFBLOODARETRANSFUSEDEACHYEARWITHOUTTESTINGFORHIVORHEPATITISBLOODTRANSFUSIONISTHESECONDLARGESTSOURCEOFTHENEWHIVINFECTIONSINNIGERIAADISEASEFREEBLOODSUBSTITUTESWOULDBESOBENEFICIALINTHESEREGIONSHEMOPUREISCURRENTLYAPPROVEDFORUSEINSOUTHAFRICATHEUNITEDSTATESARMYISWHERETHEFIRSTRESEARCHINTOPRODUCINGBLOODSUBSTITUTESWASCONDUCTEDFOLLOWINGTHEVIETNAMWARWHENYOUAREOUTONTHEBATTLEFIELDTHEARMEDFORCESWOULDDEFINITELYBENEFITFROMBLOODSUBSTITUTESBECAUSETHEREAREDIRENEEDSWHENTIMEISOFTHEESSENCEANDTYPINGBLOODISNOTONTHEPRIORITYLISTWHENITISLIFEORDEATHHEMOSPANISABLOODSUBSTITUTETHATCANBEDRIEDANDTRANSPORTEDASAPOWDERSTOREDFORYEARSANDTHENRECONSTITUTEDASLIQUIDBEFORETRANSFUSIONTHISWOULDHAVEBEENTREMENDOUSIMPLICATIONFORTHEMILITARYASITWOULDBEVERYEASYTOADMINISTERHEMOSPANDOESNOTEVENREQUIRETYPINGTHEREAREOTHERTYPESOFBLOODSUBSTITUTESINTHEWORKINGASWELLSUCHASHEMOTECHTHATELIMINATESTHENEEDTOMATCHBLOODTYPESBETWEENPATIENTSANDDONORSBECAUSEPUREHEMOGLOBINISNOTAFFECTEDBYVARYINGFACTORSFOUNDINHUMANBLOODINADDITIONHEMOTECHHASASHELFLIFEOFATLEASTDAYSSIGNIFICANTLYLONGERTHANTHETYPICALDAYPERIODDURINGWHICHDONATEDBLOODCANBEUSEDIWASABLETOSPEAKWITHTHECHIEFOFMEDICALOPERATIONSLOCATEDATLACKLANDAIRFORCEBASESANANTONIOTEXASANDHEWASEXPLAININGTOMEHOWTHEMILITARYHASAVESTEDINTERESTINTHESUCCESSOFBLOODSUBSTITUTESDURINGOURCONVERSATIONHESPOKETOMEONTHESAFETYOFBLOODSUBSTITUTESDURINGHIVINFECTIONTESTRESULTSCANBENEGATIVEASANTIBODIESMAYNOTHAVEFORMEDBLOODSUBSTITUTESCOULDLOWERTHENUMBEREVENMORELASTYEARITRIEDDONATINGBLOODBUTISPENTTIMEINENGLANDANDDUETOMADCOWSDISEASEIWASUNABLETODONATECURRENTLYTHEREISNOWAYTOTESTFORMADCOWSMALLPOXANDOTHERDISEASESSOTHEBLOODSUPPLYHASBEENDECREASINGJUSTTHINKOFALLTHEPEOPLETHATCOULDDONATEBLOODIFTHEREWEREOTHERMEANSOFTESTINGLASTBUTNOTLEASTBLOODSUBSTITUTESCOULDBECHEAPERCURRENTRANGEOFBLOODSUBSTITUTESRANGEBETWEENDOLLARSTHEREGIONISADETERMINATIONOFTHECOSTASWELLTHECOSTOFBLOODSUBSTITUTESWILLFALLASMANUFACTURINGISREFINED
2504 символа